Enanta Pharmaceuticals, Inc. Announces The Appointment Of George S. Golumbeski, Ph.D. To Board Of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced the appointment of George S. Golumbeski, Ph.D., to its Board of Directors. Dr. Golumbeski will also serve as a member of the Compensation Committee and the Nominating and Corporate Governance Committees.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC